• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Breakthrough Pain

Breakthrough Pain - 25 Studies Found

Withdrawn : An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.
: Pain
: 2013-04-10
: Drug: Fentanyl Citrate Nasal Spray (FCNS) Other Name: Lazanda
Completed : Sublingual Methadone for the Management of Cancer Breakthrough Pain
:
  • Cancer
  • Pain

: 2005-07-29
: Drug: Methadone
Completed : An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients
: Pain
: 2007-12-14
: Drug: tramadol hydrochloride; acetaminophen
Terminated : Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients
:
  • Cancer
  • Pain

: 2006-07-11
: Drug: Sublingual Methadone
Completed : Breakthrough Pain Computer Integrated Patient Controlled Epidural Analgesia
: Pain
: 2014-12-07
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.